Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma gangrenosum. | Canada Hyperbarics Skip to main content
Clinical Study Anais brasileiros de dermatologia 2011

Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma gangrenosum.

Vieira WA, Barbosa LR, Martin LM — Anais brasileiros de dermatologia, 2011

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers described the successful treatment of an adolescent girl with pyoderma gangrenosum using hyperbaric oxygen therapy in conjunction with corticosteroids and immunosuppressants.

What They Found

They observed that the combined therapy led to rapid wound closure and decreased discomfort in the patient. This approach resulted in an excellent outcome, with significant healing of large and painful pyoderma gangrenosum lesions.

Canadian Relevance

This study has no direct Canadian connection as it was conducted outside of Canada.

Study Limitations

A significant limitation of this study is its design as a single case report, which limits the generalizability of its findings to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Wound Care
Source Pubmed
PubMed ID 22281912
Year Published 2011
Journal Anais brasileiros de dermatologia
MeSH Terms Adolescent; Adrenal Cortex Hormones; Combined Modality Therapy; Female; Humans; Hyperbaric Oxygenation; Necrosis; Pain Management; Pyoderma Gangrenosum; Skin

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology